Resources
Benchmarks on biotech financial management.
Short, sourced analysis on cash, runway, board preparation and the R&D tax credit. The topics you need to master to decide and raise on good terms.
Biotech cash: why 75% have less than 12 months of visibility
What the 2026 Panorama France HealthTech says, and what it changes for your financial management.
Preparing a biotech board without losing sleep over it
From a spreadsheet rebuilt before every meeting to a clear, defensible scenario.
French R&D tax credit (CIR) in biotech: building your base correctly
Eligible base, operating flat rate, rates and JEI status, with the official references.
See these principles applied to your numbers.
A 30-minute demo is all it takes to go from theory to your own runway.
Request a demo